Niels J Connell

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 4

Top Topics

Body Mass Index

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Sten M M van Beek, Yvonne M H Bruls, Froukje Vanweert, Ciarán E Fealy, Niels J Connell, Gert Schaart, Esther Moonen-Kornips, Johanna A Jörgensen, Frederic M Vaz, Ellen T H C Smeets, Peter J Joris, Anne Gemmink, Riekelt H Houtkooper, Matthijs K C Hesselink, Tore Bengtsson, Bas Havekes, Patrick Schrauwen, Joris Hoeks
Effect of β2-agonist treatment on insulin-stimulated peripheral glucose disposal in healthy men in a randomised placebo-controlled trial. Nature communications 14 (1) (2023)
Sten M M van Beek, Yvonne M H Bruls, Froukje Vanweert, Ciarán E Fealy, Niels J Connell, Gert Schaart, Esther Moonen-Kornips, Johanna A Jörgensen, Frederic M Vaz, Ellen T H C Smeets, Peter J Joris, Anne Gemmink, Riekelt H Houtkooper, Matthijs K C Hesselink, Tore Bengtsson, Bas Havekes, Patrick Schrauwen, Joris Hoeks
Effect of β2-agonist treatment on insulin-stimulated peripheral glucose disposal in healthy men in a randomised placebo-controlled trial. Nature communications 14 (1) (2023)
Sten M M van Beek, Yvonne M H Bruls, Froukje Vanweert, Ciarán E Fealy, Niels J Connell, Gert Schaart, Esther Moonen-Kornips, Johanna A Jörgensen, Frederic M Vaz, Ellen T H C Smeets, Peter J Joris, Anne Gemmink, Riekelt H Houtkooper, Matthijs K C Hesselink, Tore Bengtsson, Bas Havekes, Patrick Schrauwen, Joris Hoeks
Effect of β2-agonist treatment on insulin-stimulated peripheral glucose disposal in healthy men in a randomised placebo-controlled trial. Nature communications 14 (1) (2023)
Sten M M van Beek, Yvonne M H Bruls, Froukje Vanweert, Ciarán E Fealy, Niels J Connell, Gert Schaart, Esther Moonen-Kornips, Johanna A Jörgensen, Frederic M Vaz, Ellen T H C Smeets, Peter J Joris, Anne Gemmink, Riekelt H Houtkooper, Matthijs K C Hesselink, Tore Bengtsson, Bas Havekes, Patrick Schrauwen, Joris Hoeks
Effect of β2-agonist treatment on insulin-stimulated peripheral glucose disposal in healthy men in a randomised placebo-controlled trial. Nature communications 14 (1) (2023)